Cox-2 inhibitors - safety alerts & advisory statements
- Lumiracoxib (Prexige)
- Urgent advice regarding management of patients taking lumiracoxib (Prexige)
<http://www.tga.gov.au/alerts/prexige.htm>
advice for health professionals, 13 August 2007 - Medicines Regulator cancels registration of anti inflammatory drug, Lumiracoxib
<http://www.tga.gov.au/media/2007/070811-lumiracoxib.htm>
media statement, 11 August 2007 - Urgent medicine recall - Lumiracoxib (Prexige)
<http://www.tga.gov.au/recalls/2007/lumiracoxib.htm>
recall notice, 10 August 2007
- Urgent advice regarding management of patients taking lumiracoxib (Prexige)
- Status of action on products containing meloxicam
<http://www.tga.gov.au/media/2005/050415-meloxicam.htm>
15 April 2005 - Regulator takes tough action on arthritis drugs (amends 10 February 2005 statement)
<http://www.tga.gov.au/media/2005/050225_cox2.htm>
25 February 2005 - Expanded information on Cox-2 inhibitors for doctors and pharmacists (amends 10 February 2005 statement)
<http://www.tga.gov.au/media/2005/050214_cox2.htm>
14 February 2005 - Potential safety risks with Celebrex
<http://www.tga.gov.au/media/2004/041220_celebrex2.htm>
20 December 2004 - Potential safety risks with Celebrex
<http://www.tga.gov.au/media/2004/041220_celebrex.htm>
18 December 2004 - Celecoxib (Celebrex) not withdrawn from Australian market
<http://www.tga.gov.au/media/2004/071209_celebrex.htm>
9 December 2004